Matthew Speers
Director Ejecutivo en IC-VEC Ltd. .
Perfil
Matthew Speers has been Chief Executive Officer of IC-VEC Ltd.
since 2004.
Prior to joining IC-Vec, he was a Vice President of Plexus Ventures.
Previously, he worked for GlaxoSmithKline.
Mr. Speers has 20 years of experience in the pharmaceutical industry.
Cargos activos de Matthew Speers
Empresas | Cargo | Inicio |
---|---|---|
IC-VEC Ltd.
IC-VEC Ltd. Miscellaneous Commercial ServicesCommercial Services IC-VEC Ltd. is a biotechnology firm and do research and development for non-viral drug delivery systems. The company's therapeutic areas are cancer and liver diseases. IC-VEC plans to use its technology to develop DNA based and cancer vaccines. The company was founded in December 2001 by Andrew Miller and is headquartered in London, UK | Director Ejecutivo | 01/04/2004 |
Antiguos cargos conocidos de Matthew Speers.
Empresas | Cargo | Fin |
---|---|---|
GSK PLC | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
GSK PLC | Health Technology |
Empresas privadas | 1 |
---|---|
IC-VEC Ltd.
IC-VEC Ltd. Miscellaneous Commercial ServicesCommercial Services IC-VEC Ltd. is a biotechnology firm and do research and development for non-viral drug delivery systems. The company's therapeutic areas are cancer and liver diseases. IC-VEC plans to use its technology to develop DNA based and cancer vaccines. The company was founded in December 2001 by Andrew Miller and is headquartered in London, UK | Commercial Services |
- Bolsa de valores
- Insiders
- Matthew Speers